|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 84.09 USD | +0.14% |
|
-1.28% | +7.53% |
| May. 08 | Prestige Consumer Healthcare Inc., Q4 2025 Earnings Call, May 08, 2025 | |
| May. 08 | Prestige Consumer Healthcare to Seek M&A | CI |
| Capitalization | 4.15B 3.59B 3.37B 3.05B 5.64B 357B 6.37B 39.37B 15.32B 164B 15.57B 15.24B 597B | P/E ratio 2026 * |
17.6x | P/E ratio 2027 * | 16.7x |
|---|---|---|---|---|---|
| Enterprise value | 4.78B 4.14B 3.88B 3.52B 6.49B 412B 7.34B 45.36B 17.65B 188B 17.95B 17.56B 688B | EV / Sales 2026 * |
4.16x | EV / Sales 2027 * | 4.06x |
| Free-Float |
87.23% | Yield 2026 * |
-
| Yield 2027 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: Prestige Consumer Healthcare Inc.
More recommendations
More press releases
| 1 day | +0.14% | ||
| 1 week | -1.28% | ||
| Current month | -1.98% | ||
| 1 month | -3.60% | ||
| 3 months | +0.33% | ||
| 6 months | +2.03% | ||
| Current year | +7.53% |
| 1 week | 83.74 |  | 87.12 |
| 1 month | 83.74 | | 89.24 |
| Current year | 72.65 | | 90.04 |
| 1 year | 64.02 | | 90.04 |
| 3 years | 48.51 | | 90.04 |
| 5 years | 32.2 | | 90.04 |
| 10 years | 26.25 | | 90.04 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ronald Lombardi
CEO | Chief Executive Officer | 61 | 2015-05-31 |
Christine Sacco
DFI | Director of Finance/CFO | 50 | 2016-09-11 |
Phil Terpolilli
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
John Byom
BRD | Director/Board Member | 71 | 2005-12-31 |
Ronald Lombardi
CHM | Chairman | 61 | - |
Sheila Hopkins
BRD | Director/Board Member | 69 | 2014-12-31 |
| Name | Weight | AuM | 1st Jan change | |
|---|---|---|---|---|
| 0.55% | 23 M€ | -8.76% | - | |
| 0.54% | 29 M€ | -7.01% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.14% | -1.28% | +30.69% | +51.43% | 4.15B | ||
| -0.78% | +6.43% | -6.73% | +179.65% | 736B | ||
| -0.99% | +1.34% | +7.94% | -7.58% | 378B | ||
| -0.52% | +0.66% | +13.34% | +38.37% | 338B | ||
| -2.17% | -2.48% | +7.17% | -13.31% | 266B | ||
| -0.90% | -1.15% | +3.11% | +21.76% | 235B | ||
| -0.80% | +1.37% | -12.13% | +11.89% | 232B | ||
| -1.96% | +3.47% | -36.89% | -3.45% | 205B | ||
| -0.41% | +1.68% | -1.14% | +25.32% | 159B | ||
| -0.37% | +5.10% | -10.86% | -49.41% | 140B | ||
| Average | -1.14% | +1.99% | -0.55% | +25.47% | 269.12B | |
| Weighted average by Cap. | -1.26% | +2.88% | -2.51% | +53.20% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.15B 995M 934M 846M 1.56B 99.07B 1.77B 10.92B 4.25B 45.35B 4.32B 4.23B 166B | 1.18B 1.02B 955M 865M 1.6B 101B 1.81B 11.16B 4.34B 46.35B 4.41B 4.32B 169B |
| Net income | 238M 206M 193M 175M 323M 20.48B 365M 2.26B 878M 9.38B 893M 874M 34.25B | 250M 216M 203M 184M 339M 21.5B 384M 2.37B 922M 9.84B 937M 917M 35.96B |
| Net Debt | 632M 547M 513M 465M 858M 54.41B 971M 6B 2.33B 24.91B 2.37B 2.32B 90.98B | 625M 541M 507M 460M 849M 53.8B 960M 5.93B 2.31B 24.63B 2.35B 2.29B 89.97B |
More financial data
* Estimated data
Employees
600
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-06-13 | 83.97 $ | -1.37% | 222,224 |
| 25-06-12 | 85.14 $ | +0.02% | 278,547 |
| 25-06-11 | 85.12 $ | -1.75% | 302,080 |
| 25-06-10 | 86.64 $ | +1.12% | 199,361 |
| 25-06-09 | 85.68 $ | +0.73% | 240,067 |
Delayed Quote Nyse, June 13, 2025 at 04:00 pm EDT
More quotes
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
83.97USD
Average target price
88.50USD
Spread / Average Target
+5.39%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- PBH Stock
Select your edition
All financial news and data tailored to specific country editions
